Novo Nordisk's total assets for Q3 2025 were kr512.29B, an increase of 6.25% from the previous quarter. NVO total liabilities were kr342.39B for the fiscal quarter, a 9.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.